ABO blood group, hypercoagulability, and cardiovascular and cancer risk

References

• Lowe J. The blood group-specific human glycosyltransferases. Baillieres Clin Haematol 1993;6:465–490.
   PubMedGoogle Scholar
• Preston AE, Barr A. The plasma concentration of factor VIII in the normal population. Br J Haematol 1964;10:238–245.
   PubMed Web of Science ®Google Scholar
• Franchini M, Capra F, Targher G, Montagnana M, Lippi G. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 2007;5:14.
   PubMedGoogle Scholar
• Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion 2001;41:56–60.
   PubMed Web of Science ®Google Scholar
• O’Donnell JS, Lasffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001;11:343–351.
   PubMed Web of Science ®Google Scholar
• Jenkins PV, O’Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006;46:1836–1844.
   PubMed Web of Science ®Google Scholar
• Gastineau DA, Moore SB. How important are ABO-related variations in coagulation factor levels? Transfusion 2001;41:4–5.
   PubMed Web of Science ®Google Scholar
• McCallum CJ, Peake IR, Newcombe RG, Bloom AL. Factor VIII levels and blood group antigens. Thromb Haemost 1983;50:757.
   PubMed Web of Science ®Google Scholar
• Mohanty D, Ghosh K, Marwaha N, Kaur S, Chauhan AP, Das KC. Major blood group antigens—a determinant of factor VIII levels in blood? Thromb Haemost 1984;51:414.
   Web of Science ®Google Scholar
• Franchini M. Hemostasis and aging. Crit Rev Oncol Hematol 2006;60:144–151.
   PubMed Web of Science ®Google Scholar
• Seltsam A, Hallensleben M, Kollmann A, Rainer Blasczyk R. The nature of diversity and diversification at the ABO locus. Blood 2003;102:3035–3042.
   PubMed Web of Science ®Google Scholar
• Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691–1695.
   PubMed Web of Science ®Google Scholar
• Souto J, Almasy L, Muñiz-Diaz E, Soria JM, Borrell M, Bayén L, et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000;20:2024–2028.
   PubMed Web of Science ®Google Scholar
• Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem 1992;267:8723–8731.
   PubMed Web of Science ®Google Scholar
• Sarode R, Goldstein J, Sussman II, Nagel RL, Tsai HM. Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor. Br J Haematol 2000;109:857–864.
   PubMed Web of Science ®Google Scholar
• Sodetz JM, Pizzo SV, McKee PA. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem 1977;252:5538–5546.
   PubMed Web of Science ®Google Scholar
• Bronte-Stewart B, Botha MC, Krut LH. ABO blood groups in relation to ischaemic heart disease. Br Med J 1962;1:1646–1650.
   PubMedGoogle Scholar
• Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969;1:539–542.
   PubMed Web of Science ®Google Scholar
• Westerholm B, Wiechel B, Eklund G. Oral contraceptive, venous thromboembolic disease and AB0 blood type. Lancet 1971;2:664.
   PubMed Web of Science ®Google Scholar
• Mourant AE, Kopec AC, Domamiewska-Sobczak K. Blood groups and blood clotting. Lancet 1971;1:223–227.
   PubMedGoogle Scholar
• Jukic I, Bingulac-Popovic J, Dogic V, Babic I, Culej J, Tomicic M, et al. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat Med J 2009;50:550–558.
   PubMed Web of Science ®Google Scholar
• Wiggins KL, Smith NL, Glazer NL, Rosendaal FR, Heckbert SR, Psaty BM, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 2009;7:263–269.
   PubMed Web of Science ®Google Scholar
• Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008;6:62–69.
   PubMed Web of Science ®Google Scholar
• Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, et al. ABO blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica 2008;93:729–734.
   PubMed Web of Science ®Google Scholar
• Medalie JH, Levene C, Papier C, Goldbourt U, Dreyfuss F, Oron D, et al. Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med 1971;285:1348–1353.
   PubMed Web of Science ®Google Scholar
• Garrison RJ, Havlik RJ, Harris RB, Feinleib M, Kannel WB, Padgett SJ. ABO blood group and cardiovacular disease: the Framingham study. Atherosclerosis 1976;25:311–318.
   PubMed Web of Science ®Google Scholar
• Whincup PH, Cook DG, Phillips AN, Shaper AG. ABO blood group and ischaemic heart disease in British men. BMJ 1990;300:1679–1682.
   PubMed Web of Science ®Google Scholar
• Akhund IA, Alvi IA, Ansari AK, Mughal MA, Akhund AA. A study of relationship of ABO blood groups with myocardial infarction and angina pectoris. J Ayub Med Coll Abbottabad 2001;13:25–26.
   PubMedGoogle Scholar
• Biancari F, Satta J, Pokela R, Juvonen T. ABO blood group distribution and severity of coronary artery disease among patients undergoing CABG in Northern Finland. Thromb Res 2002;108:195–196.
   PubMed Web of Science ®Google Scholar
• Amirzadegan A, Salarifar M, Sadeghian S, Davoodi G, Darabian C, Goodarzynejad H. Correlation between ABO blood groups, major risk factors, and coronary artery disease. Int J Cardiol 2006;110:256–258.
   PubMed Web of Science ®Google Scholar
• Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC. ABO blood types: influence on infarct size, procedural characteristics and prognosis. Thromb Res 2008;123:200–205.
   PubMed Web of Science ®Google Scholar
• Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011;377:383–392.
   PubMed Web of Science ®Google Scholar
• Carpeggiani C, Coceani M, Landi P, Michelassi C, L’abbate A. ABO blood group alleles: a risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010;211:461–466.
   PubMed Web of Science ®Google Scholar
• Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994;88:601–607.
   PubMed Web of Science ®Google Scholar
• Suadicani P, Hein HO, Gyntelberg F. Socioeconomic status, ABO phenotypes and risk of ischaemic heart disease: an 8-year follow-up in the Copenhagen Male Study. J Cardiovasc Risk 2000;7:277–283.
   PubMedGoogle Scholar
• Wautrecht JC, Galle C, Motte S, Dereume JP, Dramaix M. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998;79:688–689.
   PubMed Web of Science ®Google Scholar
• Mercier B, Oger E, Le Gal G, Mottier D, Ferec C. Phenotypic but not allelic ABO blood group association with risk of venous thrombosis. Thromb Haemost 2005;93:388–389.
   PubMed Web of Science ®Google Scholar
• Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152–155.
   PubMed Web of Science ®Google Scholar
• González Ordóñez AJ, Medina Rodriguez JM, Martín L, Alvarez V, Coto E. The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coagul Fibrinolysis 1999;10:303–307.
   PubMed Web of Science ®Google Scholar
• Robert A, Aillaud MF, Eschwège V, Randrianjohany A, Scarabin Y, Juhan-Vague I. ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemost 2000;83:630–631.
   PubMed Web of Science ®Google Scholar
• Morelli VM, De Visser MCH, Vos HL, Bertina RM, Rosendaal FR. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 2005;3:183–185.
   PubMed Web of Science ®Google Scholar
• Tirado I, Mateo J, Soria JM, Oliver A, Martínez-Sánchez E, Vallvé C, et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 2005;93:468–474.
   PubMed Web of Science ®Google Scholar
• Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, Rosamond WD, Folsom AR. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007;5:1455–1461.
   PubMed Web of Science ®Google Scholar
• Schleef M, Strobel E, Dick A, Frank J, Schramm W, Spannagl M. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals. Br J Haematol 2005;128:100–107.
   PubMed Web of Science ®Google Scholar
• Procare-GEHT Group. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Br J Haematol 2006;135:697–702.
   PubMed Web of Science ®Google Scholar
• Paiva SG, Sabino AP, Carvalho MG, Ribeiro DD, Gomes KB, Santos MS, et al. Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients. Blood Coagul Fibrinolysis 2009;20:122–128.
   PubMed Web of Science ®Google Scholar
• Trégouët DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009;113:5298–5303.
   PubMed Web of Science ®Google Scholar
• Larsen TB, Johnsen SP, Gislum M, Moller CA, Larsen H, Sorensen HT. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 2005;3:300–304.
   PubMed Web of Science ®Google Scholar
• Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Doggen CJ. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk. Br J Haematol 2010;149:118–123.
   PubMed Web of Science ®Google Scholar
• Rios DR, Fernandes AP, Carvalho MG, Figueiredo RC, Guimarães DA, Reis DR, et al. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups. Clin Chim Acta 2011;412:425–429.
   PubMed Web of Science ®Google Scholar
• Horwich L, Evans D, McConnell R, Donohoe W. ABO blood groups in gastric bleeding. Gut 1966;7:680–685.
   PubMed Web of Science ®Google Scholar
• Evans D, Horwich L, McConnell R, Bullen M. Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer. Gut 1968;9:319–322.
   PubMed Web of Science ®Google Scholar
• Viskum K. Long-term survival of patients with gastrointestinal hemorrhage with special reference to the ABO blood Group. Scand J Gastroenterol 1972;7:55–63.
   PubMed Web of Science ®Google Scholar
• Habbick BF, Melrose AG, Grant JC. Duodenal ulcer in childhood. A study of predisposing factors. Arch Dis Child 1968;43:23–27.
   PubMed Web of Science ®Google Scholar
• Berg M. Influence of age and ABO blood groups in the precipitation of bleeding peptic ulcers. Gut 1969;10:1029–1030.
   PubMed Web of Science ®Google Scholar
• Bayan K, Tuzun Y, Yilmaz S, Dursun M, Canoruc F. Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding. Dig Dis Sci 2009;54:1029–1034.
   PubMed Web of Science ®Google Scholar
• Northfield TC. Factors predisposing to recurrent hemorrhage after acute gastrointestinal bleeding. Br Med J 1971;1:26–28.
   PubMedGoogle Scholar
• Daniel M, Jaberoo MC, Stead RE, Reddy VM, Moir AA. Is admission for epistaxis more common in Caucasian than in Asian people? A preliminary study. Clin Otolaryngol 2006;31:386–389.
   PubMed Web of Science ®Google Scholar
• Reddy VM, Daniel M, Bright E, Broad SR, Moir AA. Is there an association between blood group O and epistaxis? J Laryngol Otol 2008;122:366–368.
   PubMed Web of Science ®Google Scholar
• Leonard DS, Fenton JE, Hone S. ABO blood type as a risk factor for secondary post-tonsillectomy hemorrhage. Int J Pediatr Otorhinolaryngol 2010;74:729–732.
   PubMedGoogle Scholar
• Ionescu DA, Marcu I, Bicescu E. Cerebral thrombosis, cerebral hemorrhage, and ABO blood-groups. Lancet 1976;1:278–280.
   PubMed Web of Science ®Google Scholar
• Larsen S, Antonisen B, Marquardsen J. Cerebral infarction, cerebral hemorrhage and ABO-blood groups. Lancet 1977;1:1064.
   Web of Science ®Google Scholar
• Welsby IJ, Jones R, Pylman J, Mark JB, Brudney CS, Phillips-Bute B, et al.; for members of Cardiothoracic Anesthesiology Research Endeavours (CARE). Blood Coagul Fibrinolysis 2007;18:781–785.
   PubMed Web of Science ®Google Scholar
• Kuyvenhoven JP, Veenendaal RA, Vanderbroucke JP. Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection and the ABO blood group system. Scand J Gastroenterol 1999;34:1082–1086.
   PubMed Web of Science ®Google Scholar
• Halonen P, Linko K, Wirtavuori K, Hastbacka J, Ikkala E. Evaluation of risk factors in intraoperative bleeding tendency. Ann Chir Gynaecol 1987;76:298–302.
   PubMedGoogle Scholar
• Garcia AA, van der Heijden JF, Meijers JCM, Rosendaal FR, Reitsma PH. The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment. J Thromb Haemost 2006;4:1418–1420.
   PubMed Web of Science ®Google Scholar
• Pruissen DMO, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ, Algra A; for the SPIRIT Study Group. Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin. J Neurol 2007;254:1660–1665.
   PubMed Web of Science ®Google Scholar
• Favaloro EJ. Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder. Semin Thromb Hemost 2011;37:440–455.
   PubMed Web of Science ®Google Scholar
• Castaman G, Eikenboom JC, Bertina RM, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999;82:1065–1070.
   PubMed Web of Science ®Google Scholar
• Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993;123:893–898.
   PubMed Web of Science ®Google Scholar
• Clarke CA. Blood group and disease. In: Steiberg AG, ed. Progress in Medical Genetics. Vol 1. New York, NY: Grune and Stratton, 1961:81–119.
   Google Scholar
• Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, Nyrén O. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010;172:1280–1285.
   PubMed Web of Science ®Google Scholar
• Macafee AL. ABO blood groups and carcinoma of pancreas. Ulster Med J 1964;33:129–131.
   PubMedGoogle Scholar
• Annese V, Minervini M, Gabbrielli A, Gambassi G, Manna R. ABO blood groups and cancer of the pancreas. Int J Pancreatol 1990;6:81–88.
   PubMedGoogle Scholar
• Vioque J, Walker AM. Cancer de pancreas y tipologia sanguinea ABO: un estudio de casos y controles. Med Clin (Barc) 1991;96:761–764.
   PubMedGoogle Scholar
• Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986–990.
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424–431.
   PubMed Web of Science ®Google Scholar
• Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010;102:502–505.
   PubMedGoogle Scholar
• Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010;42:224–228.
   PubMed Web of Science ®Google Scholar
• Xie J, Qureshi AA, Li Y, Han J. ABO blood group and incidence of skin cancer. PloS One 2010;5:e11972.
   Web of Science ®Google Scholar
• Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS. ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 2011;128:482–486.
   PubMed Web of Science ®Google Scholar
• Khalili H, Wolpin BM, Huang ES, Giovannucci EL, Kraft P, Fuchs CS, Chan AT. ABO blood group and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2011;20:1017–1029.
   PubMed Web of Science ®Google Scholar
• Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. Int J Cancer 2012;130:2129–2137.
   PubMed Web of Science ®Google Scholar
• Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF, Hittelman WN. Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991;324:1084–1090.
   PubMed Web of Science ®Google Scholar
• Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. Eur J Cancer 2010;46:3345–3350.
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Kraft P, Xu M, Olsson ML, Arslan AA, Bueno-de-Mesquita HB, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the Pancreatic Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2010;19:3140–3149.
   PubMed Web of Science ®Google Scholar
• Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009;29:1958–1967.
   PubMed Web of Science ®Google Scholar
• Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAMI-1 levels. Hum Mol Genet 2010;19:1863–1872.
   PubMed Web of Science ®Google Scholar
• Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008;34:747–761.
   PubMed Web of Science ®Google Scholar
• Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol 2011;8:502–512.
   PubMed Web of Science ®Google Scholar
• Montagnana M, Favaloro EJ, Franchini M, Guidi GC, Lippi G. The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis 2010;29:489–496.
   PubMed Web of Science ®Google Scholar